Annotation Detail for ZNF559

Basic Information
Top
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ZNF559 mRNA | decreases expression | 20018196
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of ZNF559 mRNA | increases expression | 20106945
|
C014347 |
decitabine |
decitabine results in increased expression of ZNF559 mRNA | increases expression | 16367923
|
C116926 |
rofecoxib |
rofecoxib results in decreased expression of ZNF559 mRNA | decreases expression | 17070997
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D001169 |
Arthritis, Experimental |
|
rofecoxib |
4.57 | 16690336 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.53 | 18320071 19208741 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.68 | 19215824 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.44 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.44 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.21 | 19486331 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
4.45 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
rofecoxib |
4.45 | 12902858 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.11 | 18981723 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.84 | 19294695 |
MESH:D004715 |
Endometriosis |
|
rofecoxib |
5.25 | 15652904 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.15 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.28 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.70 | 12639820 12168785 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.85 | 8708960 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.74 | 19215824 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
5.05 | 15720958 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.21 | 10903974 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.45 | 17581917 |
MESH:D007410 |
Intestinal Diseases |
|
rofecoxib |
5.59 | 15831440 |
MESH:D007417 |
Intestinal Polyps |
|
rofecoxib |
5.83 | 11245490 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.16 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.54 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.08 | 12371664 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.24 | 19235587 18980019 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.43 | 17236224 19117987 18454857 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.43 | 17679729 18704418 18460780 19387464 19010910 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
6.19 | 18055864 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rofecoxib |
3.08 | 17565644 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.69 | 19470736 |
MESH:D008545 |
Melanoma |
|
decitabine |
2.28 | 16505122 17785578 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.51 | 16801185 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.62 | 18172295 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.58 | 18608210 16882708 19157545 19010910 |
MESH:D009369 |
Neoplasms |
|
decitabine |
2.87 | 19116145 19470736 17925555 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.16 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.65 | 19348381 18481113 |
MESH:D010003 |
Osteoarthritis |
|
rofecoxib |
4.59 | 16690336 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
2.74 | 19331143 19259094 |
MESH:D010149 |
Pain, Postoperative |
|
rofecoxib |
6.11 | 16678543 18165598 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.87 | 19294695 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.59 | 12371664 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
5.29 | 17616702 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.33 | 16882103 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.87 | 19155313 |
MESH:D013274 |
Stomach Neoplasms |
marker/mechanism |
|
| 16367923 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.63 | 17967635 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
2.84 | 19087683 17616700 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.64 | 17785578 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.71 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.16 | 17120751 |